Cargando…
Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models
Loss of bone is a common medical problem and, while it can be treated with available therapies, some of these therapies have critical side effects. We have previously demonstrated that CGS21680, a selective A(2A) adenosine receptor agonist, prevents bone loss, but its on-target toxicities (hypotensi...
Autores principales: | Larrañaga-Vera, Ane, Toti, Kiran S., Flatow, James S., Haraczy, Alexandra J., Warnick, Eugene, Rao, Harsha, Gao, Zhan-Guo, Sussman, Sarah M., Mediero, Aranzazu, Leucht, Philipp, Jacobson, Kenneth A., Cronstein, Bruce N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733060/ https://www.ncbi.nlm.nih.gov/pubmed/36494860 http://dx.doi.org/10.1186/s13075-022-02961-0 |
Ejemplares similares
-
ATP transporters in the joints
por: Larrañaga-Vera, Ane, et al.
Publicado: (2021) -
Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats
por: Åstrand, Jörgen, et al.
Publicado: (2002) -
Inhibitory role of Annexin A1 in pathological bone resorption and therapeutic implications in periprosthetic osteolysis
por: Alhasan, Hend, et al.
Publicado: (2022) -
The Bone Resorption Inhibitors Odanacatib and Alendronate Affect Post-Osteoclastic Events Differently in Ovariectomized Rabbits
por: Jensen, Pia Rosgaard, et al.
Publicado: (2013) -
Combined Pharmacotherapy with Alendronate and Desferoxamine Regulate the Bone Resorption and Bone Regeneration for Preventing Glucocorticoids-Induced Osteonecrosis of the Femoral Head
por: Sheng, Hongfeng, et al.
Publicado: (2020)